Healthcare M&A: Trends & Outlook for 2022

Robert Slavkin is the chair of the Healthcare Practice Group, a multidisciplinary team recognized nationally for representing sector participants in regulatory compliance, insurance, and transactional issues. A former healthcare corporate counsel, compliance, and privacy officer for a publicly traded healthcare company, Robert represents a variety of clients within the healthcare sector, providing guidance on complex issues and compliance with all appropriate federal and state statutes and regulations. These include federal anti-kickback, Stark laws, Medicare, Medicaid, HIPAA, and FDA regulations, as well as providing guidance on daily operational and compliance issues facing healthcare entities.

Robert has significant experience with the Affordable Care Act and the ever-evolving role accountable care plays in U.S. health reform. Additionally, Robert counsels clients on Medicare Managed Care and the Part D programs. He possesses a keen understanding of the momentous legislative changes of this sector as well as potential resulting implications.

Maintaining a robust thought leadership presence, Robert conducts frequent lectures throughout the United States on a wide array of healthcare issues, including compliance and development of compliance programs under the federal requirements, HIPAA matters, and other relevant issues. He is an active member of the American Health Lawyers’ Association, and served as Vice Chair of Publications for its Payors, Plans, and Managed Care Practice Group.

Rebecca is the Founder and CEO of Shanahan Capital Ventures, LLC, a firm dedicated to providing differentiated business resources to clients in the Health Services, Managed Care, Distribution and Pharmacy channels. SCV leverages superior industry expertise, subject matter knowledge and demonstrated excellence in real world outcomes to invest, lead, advise and accelerate the strategic goals of a broad array of start-up, small-cap, and mid-cap healthcare companies, private equity firms, national and international firms. Clients of SCV have included privately held, publicly traded and tax-exempt organizations in Pharmaceutical Manufacturing, Hospitals & Integrated Delivery Systems, Physician and Pharmacy Networks, Health Plan and PBM based Services, Specialty, Compounding and Retail Pharmacy, Disease Therapy Management & Pathways Programs, Drug Distribution and Supply Chain, Revenue Cycle Management, Health Informatics and Analytics.

Mrs. Shanahan is a Past President of the National Association of Specialty Pharmacy. She was recognized as the 2017 Healthcare Entrepreneur of the Year by the Ernst and Young for the Mountain Desert Region. In 2014 she was listed as the Female CEO leading the top woman led Inc 5000 fastest growing company.

She served as CEO of Avella Specialty Pharmacy (2014-2018). Prior to her tenure at Avella she provided Executive Leadership at Cardinal Health (2011 to 2014); Shoppers Drug Mart, Inc. of Canada (2008 to 2011); OTN Holdings, Inc.(2007); Aetna Specialty Pharmacy (2005-5007); Priority Healthcare/Express Scripts (2002-2004); University of Chicago Hospitals and Health System (1997-2002); Methodist Hospital and Health Systems (1991-1996) and Community Hospitals of Indiana. She participated on a number of Boards of Directors and served as Committee Chair person for a number of Board Committees in Compliance and Audit, including Aesyntix Health; Avella Specialty Pharmacy; Manatee Wound Care; Naryx; Oncology Plus; Priority Healthcare; and Sanovia.

Taylor Phelps is a Managing Director with Cantor Fitzgerald in the Healthcare Investment Banking Group.  He is active in mergers and acquisitions and debt and equity capital raises.   He leads the firm’s efforts in healthcare services coverage in the supply chain and value based care sectors.  Over his career he has facilitated over 70 advisory and capital markets transactions for an aggregate consideration of over $20 billion.